| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2882736 | The Annals of Thoracic Surgery | 2006 | 7 Pages |
Abstract
Lung cancer patients with single-level N2 disease are an oncologically heterogeneous cohort. Although further studies involving randomized comparisons are required, the poor outcomes found here indicate that the initial operation has yet to be validated for patients with this disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yasuhiko MD, Yosuke MD, Hiroshi MD, Isao MD, Makoto MD, Go MD,